pcDNA3-RAGE Citations (5)
Originally described in: Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways.Huttunen HJ, Fages C, Rauvala H J Biol Chem. 1999 Jul 9;274(28):19919-24. PubMed
Articles Citing pcDNA3-RAGE
| Articles |
|---|
| S100A4 is secreted by airway smooth muscle tissues and activates inflammatory signaling pathways via receptors for advanced glycation end products. Wu Y, Zhang W, Gunst SJ. Am J Physiol Lung Cell Mol Physiol. 2020 Jul 1;319(1):L185-L195. doi: 10.1152/ajplung.00347.2019. Epub 2020 May 20. PubMed |
| Molecular mechanism of dihydropyrazine-induced cytotoxicity: the possibility of an independent pathway from the receptor for advanced glycation end products. Miyauchi Y, Sawai M, Ishida T, Kansui H, Takechi S. J Toxicol Sci. 2021;46(11):509-514. doi: 10.2131/jts.46.509. PubMed |
| TIRAP drives myelosuppression through an Ifngamma-Hmgb1 axis that disrupts the endothelial niche in mice. Gopal A, Ibrahim R, Fuller M, Umlandt P, Parker J, Tran J, Chang L, Wegrzyn-Woltosz J, Lam J, Li J, Lu M, Karsan A. J Exp Med. 2022 Mar 7;219(3). pii: 212987. doi: 10.1084/jem.20200731. Epub 2022 Jan 28. PubMed |
| Focal Adhesion Kinase (FAK)-Hippo/YAP transduction signaling mediates the stimulatory effects exerted by S100A8/A9-RAGE system in triple-negative breast cancer (TNBC). Rigiracciolo DC, Nohata N, Lappano R, Cirillo F, Talia M, Adame-Garcia SR, Arang N, Lubrano S, De Francesco EM, Belfiore A, Gutkind JS, Maggiolini M. J Exp Clin Cancer Res. 2022 Jun 3;41(1):193. doi: 10.1186/s13046-022-02396-0. PubMed |
| The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells. Talia M, Cirillo F, Spinelli A, Zicarelli A, Scordamaglia D, Muglia L, De Rosis S, Rigiracciolo DC, Filippelli G, Perrotta ID, Davoli M, De Rosa R, Macirella R, Brunelli E, Miglietta AM, Nardo B, Tosoni D, Pece S, De Francesco EM, Belfiore A, Maggiolini M, Lappano R. J Exp Clin Cancer Res. 2023 Jul 12;42(1):164. doi: 10.1186/s13046-023-02747-5. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.